Anterogen Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Anterogen Co Ltd with three other
companies in this sector in KOREA (SOUTH) :
sales of 4.25 billion Korean Won [US$3.48 million]
of which 86%
was Wholesale of Medicine and Medical Suppli),
(4.37 billion Korean Won [US$3.58 million]
of which 67%
was Medical Segment), and
Cube&Company Co Ltd
(7.38 billion Korean Won [US$6.05 million]
of which 98%
Anterogen Co Ltd reported sales of 4.15 billion Korean Won (US$3.40 million)
December of 2019.
increase of 15.0%
versus 2018, when the company's sales were 3.61 billion Korean Won .
Despite this increase, sales are still
below the level achieved in 2017, when Anterogen Co Ltd
reported sales of 5.36 billion Korean Won .
Sales of Remodulins saw an increase
20.6% in 2019, from
2.67 billion Korean Won to 3.22 billion Korean Won .
Not all segments of Anterogen Co Ltd experienced an increase in sales in 2019:
sales of Sevice&technical fell 97.3% to 3.00 million Korean Won .
(However, this segment's sales were only a very small portion of the company's overall sales).